OTR3  
Investors

liseret1
liseret2

OTR3 is a clinical-stage regenerative medical device company developing novel matrix therapies to improve the lives of patients suffering from dermatological and neurological diseases with large unmet medical needs. The company currently is engaged in the development of a second generation of products based on the RGTA® technology while expanding the geographical presence of its marketed products :

Subscribe and receive our corporate presentation

investors

OTR3 presences at events for investors

No post was found with your current grid settings. You should verify if you have posts inside the current selected post type(s) and if the meta key filter is not too much restrictive.
liseret1
liseret2
Investors
Investors

Organes Tissus Regeneration Reparation Remplacement

© 2022 – OTR3 – All rights reserved

ADDRESS

4, rue Française
75001 Paris, France

© 2022 – OTR3 – All rights reserved